Are persistent gaps undermining sustainability reporting progress in Australia?

Are persistent gaps undermining sustainability reporting progress in Australia?

Health Industry Hub | August 23, 2023 |

In a stride toward environmental sustainability, the majority of Australia’s ASX200 companies are embracing mandatory climate reporting, setting a promising […]

More

Market Research & Insights

Market Research Pharma Biotech MedTech - Clarivate patient centricity report underscores need for evolution from selling products to building relationships

Clarivate patient centricity report underscores need for evolution from selling products to building relationships

Health Industry Hub | April 6, 2022 |

Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release […]

More

Market Research & Insights

The future of the generics landscape: Key branded drugs losing exclusivity in 2021 and beyond

Health Industry Hub | November 3, 2021 |

Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of […]

More

Market Research & Insights

Patient centricity has long been at the heart of medical innovation, but today shapes its future

Health Industry Hub | October 20, 2021 |

Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of […]

More

Market Research & Insights

Market Research Pharma Biotech MedTech - Clarivate forecasts impact of COVID-19 vaccines on healthcare market and insights on market recovery

Clarivate forecasts nearly 70% of Asia Pacific, North American and European adult populations will be vaccinated for COVID-19 by September 2021

Health Industry Hub | August 4, 2021 |

A new report analyses how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across […]

More

Market Research & Insights

Market Research Pharma Biotech MedTech - 2021 outlook for pharma mergers and acquisitions

2021 outlook for pharma mergers and acquisitions

Health Industry Hub | January 25, 2021 |

Market Research & Insights: A recent PwC report indicated an optimistic 2021 for the pharmaceutical and life sciences (PLS) sector […]

More

Market Research & Insights

Market Research Pharma Biotech MedTech -

What high-performing MedTech companies are doing differently

Health Industry Hub | January 11, 2021 |

Market Research & Insights: Innovation and product development (I&PD) in the MedTech sector is costly. A strong I&PD strategy can help […]

More

Market Research & Insights

Market Research Pharma Biotech MedTech - New MTPConnect report identifies skills priorities for future workforce in Pharma, MedTech and Biotech

New report identifies skills priorities for future workforce of Pharma, MedTech and Biotech

Health Industry Hub | November 13, 2020 |
Please log in to Health Industry Hub to view this content.
More

Market Research & Insights

Market Research Pharma Biotech MedTech - MedTech leaders prioritise innovation and technology

MedTech leaders prioritise innovation and technology

Health Industry Hub | October 21, 2020 |

Please log in to Health Industry Hub to view this content in the Market Research & Insights menu.

More

Market Research & Insights

Market Research Pharma Biotech MedTech - Workforce gaps in Australian MedTech, Pharma, Biotech and digital health sectors

Workforce gaps in Australian MedTech, Pharma, Biotech and digital health sectors

Health Industry Hub | October 19, 2020 |

Australia’s medical technology, biotechnology, pharmaceutical and digital health sector supports approximately 70,000 Australian jobs and contributed more than $5 billion […]

More

Market Research & Insights

Market Research Pharma Biotech MedTech - New report highlights impact of COVID-19 on cancer screening

New report highlights impact of COVID-19 on cancer screening

Health Industry Hub | October 9, 2020 |

Please log in to Health Industry Hub to view this content in the Medical sub-menu.

More

Recent Posts in Pharma, MedTech & Biotech

Health sector faces new privacy obligations
By Health Industry Hub
September 11, 2026 in Digital & Innovation

TGA approves new antibiotic but AMR blind spot remains a critical concern
By Health Industry Hub
September 11, 2026 in News - Pharmaceuticals

BCAL Diagnostics rejects merger speculation
By Health Industry Hub
September 11, 2026 in News - MedTech & Diagnostics

Australia backs infectious disease innovation as US funding faces more cuts
By Health Industry Hub
September 11, 2026 in News - Pharmaceuticals

GenesisCare debuts first next-gen radiosurgery platform in Australia
By Health Industry Hub
September 10, 2026 in News - MedTech & Diagnostics

TGA grants licence to Australia’s first viral vector manufacturing facility
By Health Industry Hub
September 10, 2026 in News - Biotechnology

Rare cancers, submarines and the price of the messy middle
By Health Industry Hub
September 10, 2026 in News - Pharmaceuticals

The ‘rare’ case for a reform agenda that changes the reflection
By Health Industry Hub
September 8, 2026 in News - Pharmaceuticals

  • Follow Us

  • Partner with us

    Build thought leadership, differentiate your organisation and let us help you connect with Pharma, MedTech, Diagnostics and Biotech industry professionals.

    To find out how you can engage with Health Industry Hub’s audience click here.

  • Digital & Innovation

    Health sector faces new privacy obligations

    Health sector faces new privacy obligations

    Health Industry Hub | September 11, 2026 |

    Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]

    More


    News - Pharmaceuticals

    TGA approves new antibiotic but AMR blind spot remains a critical concern

    TGA approves new antibiotic but AMR blind spot remains a critical concern

    Health Industry Hub | September 11, 2026 |

    The Therapeutic Goods Administration (TGA) has approved a new antibiotic for the treatment of carbapenem-resistant Gram-negative bacterial infections. Developed by […]

    More


    News - MedTech & Diagnostics

    BCAL Diagnostics rejects merger speculation

    BCAL Diagnostics rejects merger speculation

    Health Industry Hub | September 11, 2026 |

    ASX-listed BCAL Diagnostics has moved to quash speculation of a potential three-way merger involving Genetic Signatures and Microba Life Sciences, […]

    More


    News - Pharmaceuticals

    Australia backs infectious disease innovation as US funding faces more cuts

    Australia backs infectious disease innovation as US funding faces more cuts

    Health Industry Hub | September 11, 2026 |

    Biointelect Venturer, a national incubator supporting infectious disease innovation, will open its second funding round later this month, with AUD […]

    More


    This content is copyright protected. Please subscribe to gain access.